Total Payments
$6,097
2024 Payments
$706.42
Companies
32
Transactions
358
Medicare Patients
8,114
Medicare Billing
$485,689
Payment Breakdown by Category
Food & Beverage$5,784 (94.9%)
Education$312.98 (5.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,784 | 350 | 94.9% |
| Education | $312.98 | 8 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,300 | 102 | $0 (2024) |
| Janssen Biotech, Inc. | $706.07 | 33 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $563.91 | 36 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $470.59 | 17 | $0 (2024) |
| Lilly USA, LLC | $441.71 | 26 | $0 (2024) |
| PFIZER INC. | $363.94 | 29 | $0 (2024) |
| Celgene Corporation | $290.19 | 16 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $272.75 | 9 | $0 (2024) |
| Amgen Inc. | $247.91 | 13 | $0 (2024) |
| UCB, Inc. | $196.77 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $706.42 | 45 | ABBVIE INC. ($140.25) |
| 2023 | $1,175 | 58 | ABBVIE INC. ($314.47) |
| 2022 | $337.93 | 24 | ABBVIE INC. ($187.09) |
| 2020 | $258.77 | 13 | Sun Pharmaceutical Industries Inc. ($88.29) |
| 2019 | $1,594 | 88 | AbbVie, Inc. ($299.90) |
| 2018 | $977.20 | 60 | AbbVie, Inc. ($117.01) |
| 2017 | $1,048 | 70 | AbbVie, Inc. ($186.74) |
All Payment Transactions
358 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Immunology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.07 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Immunology | ||||||
| 11/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $35.21 | General |
| Category: Immunology | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: DERMATOLOGY | ||||||
| 10/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological), ILUMYA | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.36 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.09 | General |
| Category: Immunology | ||||||
| 09/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: Immunology | ||||||
| 09/11/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: DERMATOLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.02 | General |
| Category: IMMUNOLOGY | ||||||
| 09/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Immunology | ||||||
| 08/28/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: DERMATOLOGY | ||||||
| 08/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Inflammation | ||||||
| 07/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.90 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Immunology | ||||||
| 07/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.91 | General |
| Category: Immunology | ||||||
| 07/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,968 | 3,507 | $342,258 | $120,433 |
| 2022 | 12 | 1,981 | 3,577 | $313,675 | $116,686 |
| 2021 | 14 | 2,032 | 3,591 | $306,851 | $126,749 |
| 2020 | 14 | 2,133 | 3,310 | $330,859 | $121,822 |
Total Patients
8,114
Total Services
13,985
Medicare Billing
$485,689
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 686 | 943 | $141,450 | $49,518 | 35.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 396 | 542 | $59,620 | $18,748 | 31.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 213 | 251 | $41,415 | $15,354 | 37.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 91 | 104 | $18,720 | $7,654 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 88 | $18,568 | $7,381 | 39.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 271 | 1,287 | $19,305 | $5,463 | 28.3% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 29 | 39 | $9,196 | $3,759 | 40.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 54 | 84 | $6,888 | $3,038 | 44.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 21 | $6,005 | $2,428 | 40.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 61 | 67 | $6,164 | $2,178 | 35.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $6,660 | $2,095 | 31.5% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 12 | 13 | $3,467 | $1,348 | 38.9% |
| 69100 | Biopsy of ear | Office | 2023 | 15 | 18 | $2,770 | $882.29 | 31.9% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 14 | 14 | $2,030 | $585.98 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 696 | 935 | $129,413 | $48,443 | 37.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 401 | 546 | $57,120 | $18,582 | 32.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 231 | 268 | $43,462 | $16,136 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 95 | $18,762 | $7,501 | 40.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 85 | 96 | $15,830 | $6,602 | 41.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 287 | 1,403 | $15,588 | $6,188 | 39.7% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 31 | 34 | $7,624 | $3,120 | 40.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 24 | 26 | $7,035 | $2,977 | 42.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $6,128 | $2,181 | 35.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 44 | 62 | $5,240 | $2,141 | 40.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 56 | 63 | $5,291 | $2,121 | 40.1% |
About Dr. Catherine Laughlin, MD
Dr. Catherine Laughlin, MD is a Dermatology healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114961067.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Catherine Laughlin, MD has received a total of $6,097 in payments from pharmaceutical and medical device companies, with $706.42 received in 2024. These payments were reported across 358 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,784).
As a Medicare-enrolled provider, Laughlin has provided services to 8,114 Medicare beneficiaries, totaling 13,985 services with total Medicare billing of $485,689. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Springfield, MO
- Active Since 06/15/2006
- Last Updated 07/21/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1114961067
Products in Payments
- Humira (Biological) $487.21
- SKYRIZI (Biological) $452.15
- TALTZ (Drug) $441.71
- TREMFYA (Drug) $370.76
- EUCRISA (Drug) $363.94
- ILUMYA (Biological) $285.91
- COSENTYX (Biological) $282.36
- Tremfya (Drug) $273.31
- Sotyktu (Drug) $272.75
- RINVOQ (Biological) $211.13
- Otezla (Drug) $191.04
- COSENTYX (Drug) $164.24
- STELARA (Biological) $158.12
- Cimzia (Drug) $122.96
- DUPIXENT (Biological) $112.75
- Skyrizi (Biological) $100.01
- DERMATITIS - DISEASE (Drug) $94.80
- DUPIXENT DUPILUMAB INJECTION (Biological) $93.50
- DORYX (Drug) $83.20
- Enbrel (Biological) $79.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Springfield
Dr. Shannon Trotter, D.o, D.O
Dermatology — Payments: $261,835
Dermatology $261,835
Dr. Peter Demos, M.d, M.D
Dermatology — Payments: $19,423
Dermatology $19,423
Dr. Joshua Dimmick, Md, MD
Dermatology — Payments: $14,304
Dermatology $14,304
Dr. Vivianne Beyer, M.d, M.D
Dermatology — Payments: $13,294
Dermatology $13,294
Dr. Jenifer Insley, Md, MD
Dermatology — Payments: $7,868
Dermatology $7,868
Mr. Robert Deangelis, Md, MD
Dermatology — Payments: $5,096
Dermatology $5,096